Limba
|
Ceritinib (Zykadia, LDK378) dihydrochloride is a selective, orally bioavailable and ATP-competitive inhibitor of ALKwith IC50 of 0.2 nM. Ceritinib dihydrochloride also inhibits InsR, IGF-1Rand STK22Dwith IC50 of 7 nM, 8 nM and 23 nM, respectively. Ceritinib exhibits antitomor activity.
Price | 992,00 RON (preturile sunt fara TVA) |
---|---|
Description |
Ceritinib (Zykadia, LDK378) dihydrochloride is a selective, orally bioavailable and ATP-competitive inhibitor of ALKwith IC50 of 0.2 nM. Ceritinib dihydrochloride also inhibits InsR, IGF-1Rand STK22Dwith IC50 of 7 nM, 8 nM and 23 nM, respectively. Ceritinib exhibits antitomor activity. |